NDC 51662-1399

BUPIVACAINE HCI AND EPINEPHRINE

Bupivacaine Hci And Epinephrine

BUPIVACAINE HCI AND EPINEPHRINE is a Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Bupivacaine Hydrochloride; Epinephrine Bitartrate.

• Product ID: 51662-1399_99516811-56e3-9c8a-e053-2a95a90ac9cb
• NDC: 51662-1399
• Product Type: Human Prescription Drug
• Proprietary Name: BUPIVACAINE HCI AND EPINEPHRINE
• Generic Name: Bupivacaine Hci And Epinephrine
• Dosage Form: Injection, Solution
• Route of Administration: PERINEURAL
• Marketing Start Date: 2019-12-09
• Marketing Category: ANDA / ANDA
• Application Number: ANDA070968
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
• Active Ingredient Strength: 5 mg/mL; mg/mL
• Pharm Classes: Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 51662-1399-1

50 mL in 1 VIAL, MULTI-DOSE (51662-1399-1)

• Marketing Start Date: 2019-12-09
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1399-1 [51662139901]

BUPIVACAINE HCI AND EPINEPHRINE INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA070968
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-12-09

Drug Details

Active Ingredients

Ingredient	Strength
BUPIVACAINE HYDROCHLORIDE	5 mg/mL

Pharmacological Class

• Amide Local Anesthetic [EPC]
• Amides [CS]
• Local Anesthesia [PE]
• Adrenergic alpha-Agonists [MoA]
• Adrenergic beta-Agonists [MoA]
• alpha-Adrenergic Agonist [EPC]
• beta-Adrenergic Agonist [EPC]
• Catecholamine [EPC]
• Catecholamines [CS]